Stem Cell Research & Therapy: now accepting submissions

A new BioMed Central journal,Stem Cell Research & Therapy, is now accepting submissions.

Stem Cell Research & Therapyaims to be the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it will publish open access research articles of outstanding quality. The journal will have a special emphasis on translational, laboratory, and clinical research into stem cells. It will include animal trials, pre-clinical and clinical trials. We will consider adult, embryonic, and induced pluripotent stem cell research, especially with a focus on cell-based transplantation, drug discovery and testing, cell-mediated tissue response and biological effects stimulated by endogenous cells. We will have a unique focus on drug discovery and testing, stem cell manufacture, engineering, and biomaterials.

The journal is edited byDr Rocky Tuan(National Institutes of Health, USA)andProf Timothy O’Brien(National University of Ireland, Galway), and is supported by an internationalEditorial Board.

Stem Cell Research & Therapyjoins BioMed Central’s growing portfolio of journals that uniquely focus on publishing translational research of exceptional interest, as well as authoritative reviews and commentaries. Other titles in this series include the well-establishedArthritis Research & Therapy, andAlzheimer’s Research & Therapy, which is due to publish its first issue in July 2009.

For more information onStem Cell Research & Therapyplease visit the journal’sinformation pageor contact theeditorial office. To keep up to date with the latest developments and to receive a copy of the inaugural issue, pleaseregisteryour email address on the website.

Submityour next outstanding piece of research toStem Cell Research & Therapyto benefit from the rapid peer review, high visibility, and immediate and free access to all research papers.

Surayya Johar
In-house Editor
Stem Cell Research & Therapy

View the latest posts on the On Medicine homepage

Comments